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ANCA-Assay Standardisation:Background. In kidney biopsies of patients with anti-neutro-
Study Coordinators. E.C. Hagen, F.J. van der Woude, and M.R. Dahaphil cytoplasmic antibody (ANCA)-associated systemic vasculi-
(Leiden University Medical Center, Leiden, The Netherlands).tis, a variety of histopathological lesions occur, and their relation- Steering Committee. G. Gaskin and C.D. Pusey (Hammersmith Hospi-
ship to renal outcome is virtually unknown. This multicenter tal, London, UK), K. Andrassy (University of Heidelberg, Heidelberg,
European study reports a clinicopathological analysis of biop- Germany), N. Rasmussen (Rigshospitalet, Copenhagen, Denmark), A.
sies from 157 patients with systemic vasculitis. Wiik (Statens Serum Institut, Copenhagen, Denmark), F. Ferrario and
Methods. The biopsies were evaluated according to a pre- R.A. Sinico (San Carlo Borromeo Hospital, Milan, Italy), Z. Heigl
viously standardized scoring protocol. Serum creatinine values (Karolinska Institute, Stockholm, Sweden), D. Jayne and C.M. Lock-
were measured at the time of biopsy and one year later. In wood (Addenbrooke’s Hospital, Cambridge, UK), C.G.M. Kallenberg
and J.W. Cohen Tervaert (University Hospital Groningen, Groningen,addition, the lowest creatinine level during follow-up was taken
The Netherlands), Ph. Lesavre (Hoˆpital Necker, Paris, France), J. Lu¨de-into account as the optimum level of renal function recovery.
mann (Utecht and Lu¨demann, Klausdorf, Germany), F. Mascart-Lem-The clinical prognostic value of the histopathological parame-
one (Hoˆpital Erasme, Brussels, Belgium), E. Mirapeix (Hospital Clinicters was analyzed with the Kruskal–Wallis one-way analysis of
I Provincial, Barcelona, Spain), A. Tzioufas (National University ofvariance and the Mann–Whitney U-test.
Athens, Athens, Greece), J. Wieslander (Wieslab AB, Lund, Sweden),Results. The percentage of normal glomeruli correlated most
and K. de Groot and W.L. Gross (University of Lu¨beck, Bad Bramstedt,significantly with renal outcome at all points of measurement
Germany).
(all P , 0.001). Other lesions predicting for renal function were Pathology Review. (Renal biopsies): I.M. Bajema and J.A. Bruijn
glomerular sclerosis (P , 0.0005 at one year after the biopsy), (Leiden University Medical Center, Leiden, The Netherlands), L.H.
diffuse interstitial infiltrates (P , 0.0001 at entry, P , 0.0003 Noe¨l (Hoˆpital Necker, Paris, France), R. Waldherr (University of Hei-
at one year), tubular necrosis (P , 0.0025 at entry), and tubular delberg, Heidelberg, Germany), and F. Ferrario (San Carlo Borromeo
atrophy (P , 0.002 at entry, P , 0.0002 at one year). Hospital, Milan, Italy). (Respiratory tract biopsies): B. Ravn Juhl and
Conclusion. Traditionally, attention is focused on the extent C.B. Andersen (Rigshospitalet, Copenhagen, Denmark).
Statistical Analysis. J. Hermans and B.E. Hansen (Leiden Universityof active lesions in the renal biopsy in order to determine the
Medical Center, Leiden, The Netherlands).severity of renal disease and its implication for renal outcome.
Data Management. M.J.K. Mallat (Leiden University Medical Center,Because of their significant impact on renal function, combined
Leiden, The Netherlands).with their easy recognition, we recommend the use of the
Participating Investigators. E. Csernok (Rheumaklinik Bad Bramstedt,percentage of normal glomeruli in an adequate biopsy in pre-
University of Lu¨beck, Bad Bramstedt, Germany), M. de Waele (Acade-dicting renal function of patients with systemic vasculitis.
misch Ziekenhuis Vrije Universiteit, Brussels, Belgium), W. Szpirt and
J. Petersen (Rigshospitalet, Copenhagen, Denmark), C. Geffriaud
(Hoˆpital Necker, Paris, France), G. Gregorini (Ple Spedali Civili, Bres-
cia, Italy), M. Quarenghi (Ospedale S. Anna, Como, Italy), A. Lopez
Soto (Hospital Clinic I Provincial, Barcelona, Spain), E. Pettersson
(Huddinge University Hospital, Huddinge, Sweden), J. Berglund, T.
Zweig and S. Jacobson (Karolinska Institute, Stockholm, Sweden), P.
Chapman (Addenbrooke’s Hospital, Cambridge, UK).
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Borromeo Hospital, Milan, Italy), J.M. Flodman (Karolinska Institute,
Received for publication October 12, 1998 Stockholm, Sweden), and A. Coulthart (Hammersmith Hospital, Lon-
and in revised form May 28, 1999 don, UK). (Provided biopsy material) M. Thompson (Hammersmith
Accepted for publication June 4, 1999 Hospital, London, UK) and S. Thiru (Addenbrooke’s Hospital, Cam-
bridge, UK). 1999 by the International Society of Nephrology
1751
Bajema et al: ANCA-associated glomerulonephritis1752
Renal involvement in systemic vasculitis is histopatho- were not analyzed separately because the data from both
groups were comparable. The number of glomeruli inlogically characterized by a number of lesions such as
extracapillary proliferation and fibrinoid necrosis. Non- all patients ranged from 4 to 132, with a mean of 15
glomeruli and a median of 11 glomeruli in the biopsy.active lesions such as focal or global glomerular sclerosis
also may be seen. In the interstitium, tubular damage,
Patient classificationinfiltrates, and vasculitis of arteries and arterioles may
be found. Among patients with systemic vasculitis, there As the majority of patients from this study were re-
cruited before the Chapel Hill Consensus Conference inis a wide variety in the incidence of these lesions. Next
to active and chronic lesions, unaffected glomeruli may the nomenclature of systemic vasculitis [10, 11], after
study entrance, they were reclassified according to defi-occur as well.
Renal failure as a cause of death in systemic vasculitis nitions based on this classification system. The following
diagnostic groups were formed:has decreased in frequency over the past decades; how-
ever, it still attains a number one position as a fatal factor Wegener’s granulomatosis (WG). These patients were
divided into three subgroups. (1) Patients with histologi-[1], especially because of adverse effects of treatment.
Previous research addressing the relationship in systemic cally proven vasculitis with granuloma and/or giant cells
in a biopsy specimen (either renal or extrarenal location);vasculitis between histopathological renal lesions and
renal outcome has produced contradictory results [2–8]. (2) patients with clinical evidence of at least one airway
symptom or sign compatible with WG (pulmonary nod-Alternatively, extracapillary proliferation, fibrinoid ne-
crosis, glomerular sclerosis, interstitial inflammation, and ules or fixed infiltrates, sinusitis, purulent or bloody dis-
charge from the nose, saddle nose, otitis media, orbitalacute tubular damage have been put forward as the most
likely candidates to predict the degree of renal function. pseudotumor, tracheal stenosis), with renal histology
showing crescentic and/or necrotizing glomerulonephri-It has also been claimed that the severity of histological
alteration has no relationship at all to renal outcome [9]. tis with few or no immune deposits; and (3) patients with
clinical evidence of airway symptoms compatible withA comparison between studies is difficult because of
WG, with no histological evidence of the vasculitic na-large differences in entrance criteria, the type of lesions
ture of the disease.evaluated, and the way renal outcome was measured.
Microscopic polyangiitis (MPA). Inclusion criteria forWe currently report the results of the largest study of
patients were histologically proven crescentic and/or nec-systemic vasculitis described to date. Renal biopsy results
rotizing glomerulonephritis with few or no immune de-from 157 patients with systemic vasculitis from 14 Euro-
posits, or histologically proven vasculitis of small vesselspean centers were assembled together with their clinical
and systemic manifestations of disease compatible withdata, and their renal histopathology was correlated to
vasculitis, but no airway symptoms compatible with WGrenal function both at the time of biopsy and during
(discussed earlier in this section).follow-up.
Idiopathic rapidly progressive glomerulonephritis. This
classification included patients with histologically proven
METHODS crescentic and/or necrotizing glomerulonephritis with
This study was part of the EC/BCR Project for ANCA- few or no immune deposits, without systemic disease
Assay Standardisation [10], a multicenter European study manifestations.
in which patients were entered both retrospectively and Classical polyangiitis nodosa (classical PAN). This en-
prospectively. From each center, the last 15 to 20 patients compassed patients with proof of arterial vasculitis (ei-
and the first 15 new patients with Wegener’s granuloma- ther by angiography or by biopsy), and criteria of small
tosis (WG), microscopic polyangiitis, Churg–Strauss syn- vessel vasculitis at any biopsy location or crescentic glo-
drome (CSS), or idiopathic rapidly progressive glomeru- merulonephritis excluded the patient from this category,
lonephritis (iRPGN) seen in a period of two years were and moved him or her into the MPA group (discussed
included. earlier in this section).
One hundred and ninety-three renal biopsies from Churg–Strauss syndrome (CSS). The following were
178 patients were available for evaluation. Follow-up classified with CSS: patients with histologically proven
biopsies (N 5 15) and biopsies with less than three glo- vasculitis or crescentic glomerulonephritis or giant cells/
meruli (N 5 16) were excluded. Five patients were lost granuloma formation in combination with asthma and
to follow-up. This left us with a total number of 157 eosinophilia.
biopsies for the clinicopathological analysis. Seventy- All patients were followed up for at least one year.
seven biopsies were from “historical” patients, and 80
Therapywere from “new” patients. Because the aim of this study
was to correlate renal function at the time of biopsy and At study entrance, 42 patients received intravenous
pulsed regimen therapy with prednisone (N 5 16), cyclo-during follow-up, the historical and the new patients
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phosphamide (N 5 10), or prednisone and cyclophospha- receiver operating characteristic (ROC) curves. The cut-
off value for PR3 antibody positivity was set at 500 andmide (N 5 16), mostly in combination with oral doses
of prednisone and/or cyclophosphamide. Of the other for MPO antibody positivity at 1500.
patients, 102 were on oral therapy with prednisone (N 5
Immunofluorescence28), cyclophosphamide (N 5 6), prednisone and cyclo-
phosphamide (N 5 52), prednisone and azathioprine (N 5 A scoring form for immunofluorescence (IF) data was
created to be filled in by the participating centers. IgG,14), prednisone, azathioprine, and cotrimoxazole (N 5 1),
or azathioprine (N 5 1). In addition to intravenously IgA, IgM, C3, C1Q, and fibrin/fibrinogen were scored
on aspect (granular or linear), intensity (0 5 absent; 1 5pulsed or oral therapy, 17 patients were on hemodialysis.
Thirteen patients received no therapy at study entrance. positive; 2 5 strongly positive), and site (mesangial, pe-
ripheral, or outside the glomerular tuft, including cres-During the follow-up, intravenously pulsed therapy
was discontinued in 28 patients and was newly started cents and/or necrosis). Also, deposits in arteries, arteri-
oles, and the tubular basement membrane were scored.in 8. All other patients received oral therapy consisting
of combinations of prednisone, cyclophosphamide, aza-
Scoring renal histopathologythioprine, and cotrimoxazole.
Four specialized renal pathologists (J.A.B., F.F.,
Scoring renal function L.H.N., and R.W.) evaluated the biopsies according to
a scoring protocol; the standardization was described inThe serum creatinine was used as an indicator of renal
function. Serum creatinine was measured both at entry a previous study [15]. Within a renal biopsy specimen,
each glomerulus had to be scored separately on the pres-and at one-year follow-up. Furthermore, creatinine val-
ues were determined at three-month intervals. A contin- ence of fibrinoid necrosis, extracapillary proliferation
(cellular/fibrous and segmental/circumferential), sclero-uous quality control on serum creatinine measurement
among 425 European centers, including those participat- sis (focal, segmental, or global), or any other lesion,
which was to be specified by the reviewing pathologist.ing in this study, guaranteed a deviation from the mean
of less than 5%. For this analysis, serum creatinine values Apart from these categories, granulomatous reaction
(defined as destruction of the glomerulus with an accu-were categorized into three groups: below 150 mmol/liter,
between 150 and 500 mmol/liter, and above 500 mmol/ mulation of epithelioid cells and/or giant cells) and peri-
glomerular infiltrates (defined as a dense infiltrateliter. The histopathological findings in the kidney were
correlated with the serum creatinine at entry and at one around a glomerulus without granuloma, with or without
destruction of Bowman’s capsule) were marked. Conse-year, and they were also correlated with the lowest serum
creatinine level (referred to as the optimum level) mea- quently, the percentage of glomeruli with any of these
features could be calculated as a fraction of the totalsured during follow-up, to exclude the distortion caused
by relapses that could have occurred within the first year number of nonsclerotic glomeruli in the biopsy. Subse-
quently, the percentages were recoded on a three-pointof follow-up.
scale: 0 for 0%, 1 for a percentage ,50%, and 2 for
Antineutrophil cytoplasmic antibody testing a percentage $50%. Each biopsy was scored by two
pathologists independently. Disagreements between theAn indirect immunofluorescence (IIF) test was per-
formed locally by all participating centers by using an pathologists on the final three-point scale were solved
in plenary sessions in which they had to re-review theIgG-specific FITC conjugate. The locally used IIF method-
ology has proven to be comparable among the centers biopsies and come to agreement. Interstitial data were
evaluated according to a two-point (2/1) or three-pointwith respect to the antineutrophil cytoplasmic antibody
(ANCA) pattern scored [12]. The IIF test was scored as (2/1/11) scale. For these data, a final scoring was estab-
lished.cytoplasmic (cANCA), perinuclear (pANCA), atypical,
or negative staining [13] using the cut-off screening dilu-
Statisticstion used routinely in each laboratory.
Sera were tested for the presence of anti-PR3 and anti- All statistical analyses were carried out with the SPSS
package for Windows. The Kruskal–Wallis one-waymyeloperoxidase (anti-MPO) antibodies in an enzyme-
linked immunosorbent assay (ELISA) format. For anti- analysis of variance was used to evaluate serum creati-
nine in case of histopathological parameters measuredPR3 antibody detection, three antigens were used and
isolated from human neutrophils by three different meth- on a three-point scale. The Mann–Whitney U-test was
applied for interstitial data scored on a two-point scale.ods [14]. For anti-MPO detection, one antigen was used.
ELISAs were performed in a standardized manner that Both tests were used to correlate the pathological renal
findings with the serum creatinine at entry, at one yearhad previously shown acceptable results and reproduci-
bly low variation between the participating centers [12]. after the biopsy, and at the time of the optimum (that
is, the lowest) creatinine level. The patients were dividedCut-off values for assay positivity were derived from
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Table 1. Patient characteristics
Percentage of patients with
entry serum creatinine
Diagnosis N Male:female Mean age ,150 150–500 .500 or on HD
Wegener’s granulomatosis 88 38:50 58 19 49 32
MPA 43 27:16 62 16 58 26
iRPGN 16 9:7 59 6 44 50
CSS 7 2:5 61 29 42 29
Percentage of patients with Percentage of patients with
optimum serum creatinine serum creatinine at 1 year
Diagnosis ,150 150–500 .500 or on HD ,150 150–500 . 500 or on HD
Wegener’s granulomatosis 63 25 12 43 42 15
MPA 55 37 8 33 56 11
iRPGN 44 38 18 44 31 25
CSS 71 29 0 42 58 0
Abbreviations are: HD, hemodialysis; MPA, microscopic polyangiitis; iRPGN, idiopathic rapidly progressive glomerulonephritis; CSS, Churg Strauss syndrome.
into three clinical groups according to the following crite- anti-MPO ELISA at a later time. In the group of patients
with double positivity for both anti-PR3 and anti-MPOria: serum creatinine less than 150 mmol/liter, between
150 and 500 mmol/liter, and above 500 mmol/liter. Pa- antibodies, seven had a positive anti-PR3 assay in three
cases, four in two, and one in one case. We analyzedtients on hemodialysis were registered into the last
whether significant differences in renal histopathologygroup, irrelevant of their actual serum creatinine.
occurred based on the ANCA test results but found onlyBecause an extensive number of histopathological pa-
minor differences between the patient groups (abstract;rameters were correlated with the same clinical values,
Bajema et al, J Am Soc Nephrol 8:532A, 1997).the P value at which differences were regarded as statisti-
cally significant was set to 0.0025, according to the Bon-
Immunofluorescenceferroni formula [16].
In 22 of 157 cases, IF was either not performed or the
specimen contained insufficient material for evaluation.
RESULTS
Of the remaining 135 cases, 25 were negative on all
Patient classification and extrarenal symptoms categories. Results of biopsies positive for either Ig, com-
plement, or fibrin/fibrinogen are given in Table 3. IgOf the 157 patients entered into this study, 88 were
diagnosed with WG, 43 with MPA, 16 with iRPGN, and deposits in glomeruli were never scored as strongly posi-
tive (11) but, if present, as positive (1); only in arteri-7 with CSS (Table 1). Their mean age at entrance was
not significantly different among the four groups. Subca- oles did infrequent strongly positive deposits of IgM, C3,
C1Q, and fibrin/fibrinogen occur. In 48 patients, cres-tegorization according to serum creatinine values at en-
try and during follow-up is listed in Table 1. Except for cents and areas of fibrinoid necrosis showed positive or
strongly positive staining for fibrin/fibrinogen. Glomeru-the patients with iRPGN, all patients had extrarenal
manifestations (Fig. 1). lar IgA deposits were only reported in combination with
at least two other categories positive for IF. A very weak
Antineutrophil cytoplasmic antibody test results linear staining for either IgG or IgA was reported in five
Table 2 lists the results of the ELISA and the IIF test and three patients, respectively; however, in view of the
for ANCA testing. Of seven historical patients, serum focality of the staining pattern, its weak intensity, and
was not available. Because the ELISA for anti-PR3 anti- the absence of anti-GBM antibodies in their sera, anti-
bodies was performed three times for each patient, it GBM nephritis was not considered likely.
would be conceivable that only one or two of the test
Histopathologyresults were positive. However, this occurred only in a
minority of cases; there was concordance between the Glomerular data. As is illustrated in Figure 2, the per-
centage of normal glomeruli in the biopsy proved to bethree PR3 ELISAs in all but two cases (who tested posi-
tive on 2 out of 3 ELISAs). All pANCA patients with a highly predictive parameter to estimate renal function,
both at the time of biopsy and during follow-up. At theanti-MPO antibodies had negative ELISA test results
on all three anti-PR3 assays. Of those patients marked time of biopsy (Fig. 2A), those patients with more than
50% normal glomeruli in the renal biopsy also clinicallyas double negatives, six were positive on an anti-PR3
ELISA in one out of three cases, and one had a positive fell into the lower creatinine levels. Most of the patients
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Fig. 1. Extrarenal symptoms.
Table 2. ANCA test results in 150 patients At one year after the renal biopsy, the amount of
glomerular sclerosis in the initial biopsy proved to beIIF ELISA Number of patients
predictive of renal function, with higher creatinine valuesNot performed Anti-PR3 antibodies 1
Anti-MPO antibodies 2 in those patients whose biopsy had shown the highest
cANCA Anti-PR3 antibodies 39 amounts of glomerular sclerosis (Fig. 3).
Anti-MPO antibodies 3
Interstitial data. Three interstitial histopathologicalDouble positive 5
Double negative 8 parameters showed a clear relationship to renal outcome:
pANCA Anti-PR3 antibodies 1 diffuse interstitial infiltrates, tubular necrosis, and tubu-Anti-MPO antibodies 50
lar atrophy (Table 4).Double positive 7
Double negative 5 The amount of diffuse interstitial infiltrates distin-
Atypical Anti-PR3 antibodies 2 guished the histopathological groups at both the time ofAnti-MPO antibodies 2
entry and one year later, but not at the optimum pointDouble negative 19
Negative Anti-PR3 antibodies 2 during follow-up. At the time of biopsy, serum creatinine
Anti-MPO antibodies 3 was higher in those patients with more tubular necrosis.Double negative 1
However, because of a significantly higher decrease in
creatinine in the group with the highest amount of tubu-
lar necrosis (Kruskal–Wallis one-way analysis of vari-
ance, P 5 0.002 and P 5 0.001, respectively), the groupswith only pathological glomeruli were found in the group
became clinically indistinguishable during follow-up, ir-with the highest creatinine values. The same pattern was
respective of whether this was measured at the optimumseen one year after the biopsy was taken (Fig. 2B) and
creatinine level or one year after the biopsy was taken.at the optimum point during follow-up where the lowest
The amount of tubular atrophy proved to be a consistentcreatinine levels of all patients were combined (Fig. 2C).
No significant correlations were observed between the indicator for renal function, both at entry and during
amount of extracapillary proliferation and renal function follow-up.
at entry (P , 0.03) or during follow-up (P , 0.015 both
at one year and at the optimum level). If a distinction
DISCUSSIONwas made between cellular and fibrous extracapillary
We report the results of a clinicopathological analysisproliferation, the results remained statistically insignifi-
of 157 renal biopsies from patients with systemic vasculi-cant (data not shown). Also, the amount of fibrinoid
tis. After study entrance, patients were classified as hav-necrosis did not influence renal function in terms of se-
ing WG, MPA, iRPGN, classic PAN, or CSS. Except forrum creatinine either at entry (P , 0.03) or during fol-
low-up (P , 0.4 and P , 0.2). the patients with iRPGN, all had extrarenal symptoms
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Table 3. Immunofluorescence data from the renal biopsies
Fibin/
Site of deposits IgG IgA IgM C3 C1Q fibrinogen
Mesangial 5 (5%) 2 (2%) 14 (13%) 16 (15%) 7 (6%) 6 (5%)
Peripheral 20 (18%) 6 (5%) 34 (31%) 53 (48%) 21 (19%) 12 (11%)
Crescents/areas of necrosis 1 (1%) 0 (0%) 2 (2%) 6 (5%) 2 (2%) 48 (44%)
Arterioles 0 (0%) 1 (1%) 9 (8%) 46 (42%) 9 (8%) 11 (10%)
Arteries 1 (1%) 0 (0%) 0 (0%) 9 (8%) 1 (1%) 1 (1%)
Tubular basement membrane 1 (1%) 0 (0%) 0 (0%) 6 (5%) 1 (1%) 0 (0%)
Not performed or insufficient material: 22
Negative on all categories: 25
Pauci-immune IF pattern: 110
Fig. 2. (A) Percentage normal glomeruli in the initial biopsy versus
serum creatinine at entry (Kruskal–Wallis one-way ANOVA, P ,
0.0001). (B) Percentage normal glomeruli in the initial biopsy versus
serum creatinine one year later (Kruskal–Wallis one-way ANOVA, P ,
0.0004). (C) Percentage normal glomeruli in the initial biopsy versus
the lowest serum creatinine level during follow-up (Kruskal–Wallis one-
way ANOVA, P , 0.0002).
such as upper airway disease, pulmonary disease, arthral- were quantitatively evaluated by a group of four experi-
enced renal pathologists. Each biopsy was individuallygia, and skin involvement. ANCA test results at the
time of biopsy were available of 150 patients but had scored by two pathologists, and discrepancies were re-
solved during plenary sessions. Thus, a high level ofno relationship to renal histopathology. All biopsies for
which IF data were available (N 5 135) showed a so- reliability for renal morphological scoring was guaran-
teed. Serum creatinine levels at the time of biopsy andcalled pauci-immune staining pattern, with positive or
no staining for Ig (abstract; Jennette et al, J Am Soc during follow-up served as indicators for renal function.
Although all patients in this study were treated withNephrol 7:1735, 1996). All patients received oral and/or
intravenously pulsed therapy with prednisone and/or cy- immunosuppressive therapy, their regimens were not
standardized, and therefore, an analysis of the effectclophosphamide. Renal histopathological parameters
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Table 4. P-values for correlations between interstitial renal data
and serum creatinine at entry and during follow-up
Histopathological Creatinine Optimum Creatinine one
category at entry creatinine year after biopsy
Interstitium
Edema 0.02 0.15 0.13
Focal infiltrates 0.49 0.04 0.08
Diffuse infiltrates
(mainly neutrophils) 0.0001 0.01 0.0003
Interstitial fibrosis 0.03 0.04 0.008
Granulomas 0.09 0.36 0.24
Tubuli
Casts 0.2 0.17 0.03
Necrosis 0.0025 0.46 0.3
Atrophy 0.002 0.0008 0.0002
Intra-epithelial
infiltrates 0.003 0.02 0.01
Arteries
Sclerosis 0.006 0.05 0.07
Necrosis 0.94 0.75 0.41
Infiltrates (mainlyFig. 3. Percentage sclerosed glomeruli in the initial biopsy versus serum
mononuclears) 0.67 0.47 0.97creatinine one year later (Kruskal–Wallis one-way ANOVA, P , 0.0005).
Thrombosis
(only seen in 3 cases) — — —
Scarring 0.09 0.66 0.88
Arterioles
of therapy on renal outcome in combination with the Hyalinosis 0.66 0.93 0.85
Necrosis 0.05 0.45 0.44histopathological data was not performed. A standard-
Infiltrates 0.04 0.02 0.42ized mode of treatment for patients with systemic vasculi-
Thrombosis 0.04 0.12 0.64
tis is not available, and few randomized trials have been
performed. However, prospective clinical trials are in
progress in which therapeutic regimens are prescribed
for clinical subgroupings of vasculitis, according to diag-
inine levels—normal glomeruli, sclerotic glomeruli, dif-nosis, disease extent, and severity [17].
fuse interstitial infiltrates, tubular necrosis, and tubularBoth at the time of biopsy and during follow-up, the
atrophy—we find the percentage of normal glomerulipercentage of normal glomeruli in the biopsy turned out
the most useful predictor for renal function. P values forto be the most reliable predictor for renal outcome (Fig.
its correlation to outcome were below 0.001 both at entry2). By contrast, extracapillary proliferation and fibrinoid
and during follow-up. Normal glomeruli are easy to rec-necrosis, the active glomerular lesions that serve to estab-
ognize, and their percentage of the total number of glo-lish the diagnosis of systemic vasculitis, proved not to
meruli in the biopsy is easily calculated, in contrast tobe indicative for renal function, either at entry or during
interstitial lesions, where it can be troublesome to decidefollow-up. This is in line with a recent study of 107 pa-
in what quantity they occur. Of course, it could be arguedtients with ANCA-associated MPA and glomerulone-
that the fraction of normal glomeruli is complementaryphritis—but excluding WG—which reported that the le-
to the fraction of glomeruli with active lesions and sclero-sions in the renal biopsy were not predictive of renal
sis, or, alternatively, that an index could be calculatedsurvival, except for interstitial sclerosis [18].
with the vasculitic lesions as main parameters to predictIn this study, the only active lesions predictive of renal
for renal outcome. Conceptually, such an index supportsfunction were not from a glomerular origin but from the
the idea that it is the activity of disease that ultimatelyinterstitium. The amount of diffuse interstitial infiltrates
determines how much of the kidney is spared. However,correlated with serum creatinine values at entry and dur-
active lesions such as extracapillary proliferation anding follow-up. Furthermore, tubular necrosis was signifi-
fibrinoid necrosis in our study did not show a correlationcantly more prominent in patients with high levels of
with renal function. It is conceivable that these lesionsserum creatinine at entry. Although tubular necrosis is
are partly reversible and responsive to therapy, whereasnot a specific ANCA-associated lesion, apparently its
at some point, they become irreversible, thus leading topresence is related to acute renal failure. Also nonspe-
glomerulosclerosis [19]. This may account for the factcific for systemic vasculitis syndromes are tubular atro-
that in our study, active lesions were less reliable parame-phy and glomerular sclerosis, so-called chronic lesions,
ters for renal outcome than normal glomeruli.which came out as long-term predictors of renal function:
From the present study, we conclude that the bestThe more they were present in the biopsy at entry, the
predictor for renal function in systemic vasculitis is thehigher the serum creatinine was one year later.
From the five parameters correlating with serum creat- percentage of normal glomeruli in the initial renal
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10. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E,biopsy. Because this fraction can be easily calculated,
Gaskin G, Lesavre P, Lu¨demann J, Rasmussen H, Alberto Sin-
we advocate its usage to predict renal outcome of pa- ico R, Wiik A, van der Woude FJ, for the EC/BCR Project for
ANCA Assay Standardisation: Diagnostic value of standardizedtients with systemic vasculitis.
assays for antineutrophil cytoplasmic antibodies in idiopathic sys-
temic vasculitis. Kidney Int 53:743–753, 1998
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